Gasco A M, Fruttero R, Sorba G, Gasco A, Budriesi R, Chiarini A
Dipartimento di Scienza e Tecnologia del Farmaco, Università di Torino, Italy.
Arzneimittelforschung. 1992 Jul;42(7):921-5.
A series of furazanyl- and furoxanyl-1,4-dihydropyridines has been synthesized and tested for their cardiovascular activity. The new compounds showed a modest activity in comparison with nifedipine and some selectivity for the myocardial muscle. The most active compound was diethyl 1,4-dihydro-2,6-dimethyl-4-(3-phenyl-4-furoxanyl)-3,5-pyridine dicarboxylate, 4d.
已经合成了一系列呋咱基和呋咱并[3,4 - b]吡啶基 - 1,4 - 二氢吡啶,并对其心血管活性进行了测试。与硝苯地平相比,这些新化合物显示出适度的活性,并且对心肌有一定的选择性。活性最高的化合物是1,4 - 二氢 - 2,6 - 二甲基 - 4 - (3 - 苯基 - 4 - 呋咱并[3,4 - b]吡啶基) - 3,5 - 吡啶二羧酸二乙酯,即化合物4d。